Improving interfacility patient movement is an art and a science: to be well-executed, it requires clinical judgment and aggregated data.
Interfacility patient movement is complicated in real-time, as many factors impede a standardization. Patients are often present with time-critical diagnoses and hospital’s staff must have institutional knowledge of which receiving facilities can best meet their needs. During the decision-making process, clinicians at multiple facilities quickly concur on the best course of treatment, given the constraints in place. Clear communication must continue after the patient is moved to ensure care continuity and prevent adverse outcomes.
Improving interfacility patient movement is an art and a science: to be well-executed, it requires clinical judgment and aggregated data. An interfacility transfer decision should be based on the patient’s clinical situation, current needs, available resources,and desired outcomes. By establishing a strong patient movement infrastructure and standardized processes to quantify these variables, the system can flex to meet each patient’s needs.
Common Problems Caused by Inadequate Infrastructure
When healthcare systems cannot balance care quality decisions against the convenience of compartmentalized functions, the human determinants of care are often ignored. Consider patients who have suffered an acute stroke. While it may be easier for a rural hospital to automatically transfer stroke patients to a large care center far away, a regional stroke center may offer the same care quality. When patients are admitted in closer proximity to their homes, family members can better support their care journey. Yet if the local hospital does not proactively pre-determine the patient’s return for rehabilitation services, the patient will likely complete rehab at the large referral center.
Without an adequate infrastructure for patient movement, health systems tend to accrue unnecessary expense—and cost patients chances at better outcomes. Patients are often transferred to a receiving facility only for clinicians to belatedly discover that the patient has needs they cannot meet. The patient is then transferred a second time, or even a third time, to more appropriate destinations. On a national scale, our disjointed approach to patient movement means we have no cumulative data on the number of these unfortunately common ‘skip transfers,’ .
The Critical Importance of Process Planning
Faced with high diversion rates or poor emergency services wait times, many healthcare systems simply throw money at the problem—without establishing an infrastructure to facilitate better care coordination. They might set aside funds for a new transfer center, purchase ambulances, or hire more emergency personnel without ensuring that they have the processes to make these new resources effective.
Many healthcare systems use few data points to establish best-practice guidelines for various patient circumstances. As a result, staff have little insight into responding to resource constraints, identifying an appropriate accepting facility, and communicating a provisional diagnosis and acuity assessment. Without open communication between the referring and accepting facility, patients can suffer from poor transitions in care.
For interfacility transfers to function seamlessly, with as little harm to care quality as possible, healthcare systems should ensure:
As the pandemic has shown, our healthcare system is rife with disparities in care. Without a system that connects patients in crisis with the appropriate services in a timely, deliberate manner, these gaps will only widen. By establishing an overarching infrastructure for handling urgent transfers, facilities will be better equipped to make informed decisions to maintain care quality, ease overcrowding, and ensure sustainability of the healthcare ecosystem.
Dr. Richard Watson is the co-founder of Motient, a pioneer in patient movement solutions that equip hospitals, healthcare networks, and ACOs with the data required to ensure quality care and value in patient transfers.
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen